Tarsus Pharmaceuticals
TARS
#4388
Rank
โ‚ฌ1.86 B
Marketcap
48,74 โ‚ฌ
Share price
1.25%
Change (1 day)
72.80%
Change (1 year)

Revenue for Tarsus Pharmaceuticals (TARS)

Revenue in 2024 (TTM): โ‚ฌ0.11 Billion

According to Tarsus Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.12 Billion. In 2023 the company made a revenue of โ‚ฌ15.78 Million a decrease over the revenue in the year 2022 that were of โ‚ฌ24.06 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Tarsus Pharmaceuticals from 2020 to 2024

202120222023โ‚ฌ20Mโ‚ฌ40Mโ‚ฌ60Mโ‚ฌ80Mโ‚ฌ0.1Bโ‚ฌ0.12B0companiesmarketcap.com

Annual revenue

Year Revenue Change
2024 (TTM) โ‚ฌ0.11 B651.14%
2023 โ‚ฌ15.78 M-34.42%
2022 โ‚ฌ24.06 M-52.21%
2021 โ‚ฌ50.35 M
2020 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA